Literature DB >> 170131

Regulation of protein kinase and phosphoprotein phosphatase by cyclic AMP and cyclic AMP antagonist.

H K Wasner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 170131     DOI： 10.1016/0014-5793(75)80152-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  4 in total

1.  Biosynthesis of the endogenous cyclic adenosine monophosphate (AMP) antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP), from prostaglandin E and activated inositol polyphosphate in rat liver plasma membranes.

Authors:  H K Wasner; M Lessmann; M Conrad; H Amini; E Psarakis; A Mir-Mohammad-Sadegh
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

2.  The endogenous cyclic AMP antagonist, cyclic PIP: its ubiquity, hormone-stimulated synthesis and identification as prostaglandylinositol cyclic phosphate.

Authors:  H K Wasner; U Salge; M Gebel
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

3.  Thyrotropin-induced increase in phosphoprotamine phosphatase activity in rat thyroid.

Authors:  M Roques; A Tirard
Journal:  J Endocrinol Invest       Date:  1980 Apr-Jun       Impact factor: 4.256

4.  Indomethacin treatment causes loss of insulin action in rats: involvement of prostaglandins in the mechanism of insulin action.

Authors:  H K Wasner; S Weber; H J Partke; H Amini-Hadi-Kiashar
Journal:  Acta Diabetol       Date:  1994-12       Impact factor: 4.280
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.